Skip to main content
. 2016 Oct 11;6:34710. doi: 10.1038/srep34710

Figure 1. Schematic presentation of the LIP-IND-ORA design.

Figure 1

(a) Illustration of LIP-IND-ORA structure and (b) Schematic of ORA conjugation to the LIP membrane. (c) Schematics of the LIP-IND-ORA mechanism of action: (1–2) binding to the oxytocin receptor expressed on the pregnant uterus and directing IND (yellow) specifically to the uterus (3) thereby improving the tocolytic efficacy of indomethacin while reducing its placental passage.